Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure
- 2 August 2011
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 38 (10) , 705-710
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Chronic Heart Failure: Contemporary Diagnosis and ManagementMayo Clinic Proceedings, 2010
- Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failureAnnals of Medicine, 2009
- Exercise training in patients with heart failure: clinical outcomes, safety, and indicationsHeart Failure Reviews, 2007
- Platelets and heart failureEuropean Heart Journal, 2006
- Adventures in vascular biology: a tale of two mediatorsPhilosophical Transactions of the Royal Society B: Biological Sciences, 2006
- Effects of antiplatelet therapy and oral anticoagulation on indices of endothelial damage/dysfunction in patients with systolic heart failure in sinus rhythmThrombosis Research, 2005
- Abnormalities in ?-arginine transport and nitric oxide biosynthesis in chronic renal and heart failureCardiovascular Research, 2001
- INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGETAnnual Review of Pharmacology and Toxicology, 1999
- Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductaseNature, 1991
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988